Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Olanzapine treatment for patients with schizophrenia and cocaine abuse.

Tsuang J, Marder SR, Han A, Hsieh W.

J Clin Psychiatry. 2002 Dec;63(12):1180 -1. No abstract available.

PMID:
12530415
2.

Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.

Lane HY, Guo SC, Hwang TJ, Chen YS, Cheng JJ, Lee YC, Hong CJ, Hwu HG, Chang WH.

J Clin Psychopharmacol. 2002 Oct;22(5):530-2. No abstract available.

PMID:
12352282
3.

Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.

Fanous A, Lindenmayer JP.

J Clin Psychopharmacol. 1999 Jun;19(3):275-6. No abstract available.

PMID:
10350037
4.
5.

Olanzapine on trial.

Barbui C.

Am J Psychiatry. 1998 Jan;155(1):152-3; author reply 153-5. No abstract available.

PMID:
9433358
6.

Olanzapine for schizophrenia.

[No authors listed]

Med Lett Drugs Ther. 1997 Jan 17;39(992):5-6. No abstract available.

PMID:
9008682
7.

Potential use of olanzapine in treatment of substance dependence disorders.

Sattar SP, Grant K, Bhatia S, Petty F.

J Clin Psychopharmacol. 2003 Aug;23(4):413-5. No abstract available.

PMID:
12920420
8.

Olanzapine for primary negative symptoms.

Licht RW.

Am J Psychiatry. 1998 Aug;155(8):1133-4. No abstract available.

PMID:
9699711
9.
11.

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M.

J Clin Psychopharmacol. 2006 Feb;26(1):9-12.

PMID:
16415698
12.

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.

J Clin Psychiatry. 2002 Oct;63(10):931-5.

PMID:
12416603
13.

Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.

Bronson BD, Lindenmayer JP.

J Clin Psychopharmacol. 2000 Jun;20(3):382-4. No abstract available.

PMID:
10831029
14.

Olanzapine versus other antipsychotics in the treatment of schizophrenia.

Masand PS.

J Clin Psychiatry. 2001 Oct;62(10):828-9. No abstract available.

PMID:
11816875
15.

Management of treatment-resistant schizophrenia with olanzapine.

Thomas SG, Labbate LA.

Can J Psychiatry. 1998 Mar;43(2):195-6. No abstract available.

PMID:
9533977
16.

Efficacy of olanzapine: an overview of pivotal clinical trials.

Beasley CM Jr, Tollefson GD, Tran PV.

J Clin Psychiatry. 1997;58 Suppl 10:7-12.

17.

Olanzapine treatment for patients with schizophrenia and substance abuse.

Littrell KH, Petty RG, Hilligoss NM, Peabody CD, Johnson CG.

J Subst Abuse Treat. 2001 Dec;21(4):217-21.

PMID:
11777671
18.

[Zyprexa (olanzapine)--new possibilities in the treatment of schizophrenia].

Litvintsev SV, Reznik AM, Arbuzov AL, Kutushev OT, Shcherbakov DV.

Voen Med Zh. 2002 Sep;323(9):46-50. Russian. No abstract available.

PMID:
12449756
19.

British experience with high-dose olanzapine for treatment-refractory schizophrenia.

Mountjoy CQ, Baldacchino AM, Stubbs JH.

Am J Psychiatry. 1999 Jan;156(1):158-9. No abstract available.

PMID:
9892320
20.

[Olanzapine--a new atypical neuroleptic. A chance for advancement in the therapy of schizophrenia].

[No authors listed]

Nervenarzt. 1997 Jul;68(7 Suppl Olanzapin):1-8. German. No abstract available.

PMID:
9431360

Supplemental Content

Support Center